Immunological characteristics and management considerations in obese patients with asthma.
Obesity is associated with severe, poorly controlled asthma that does not respond as well to therapy as asthma in leaner asthmatics. Important insights gained from animal models of obesity and asthma suggests that different forms of obesity may lead to different manifestations of airway disease: obesity is associated with both innate increased airway reactivity and altered responses to aeroallergen and pollutant challenges. In humans, at least two broad groups of obese asthmatics have been recognized: one that is likely unique to obesity and another that is likely lean allergic asthma much complicated by obesity. This article will discuss what we have learned about the immunological and pathophysiological basis of asthma in obesity from animal and human studies, and how this might guide therapy.
Pulmonary and Critical Care Medicine, University of Vermont College of Medicine, Given D208, 89 Beaumont Avenue, Burlington, VT 05405, USA.
Jennifer L
JL
Ather
Matthew E
ME
Poynter
Anne E
AE
Dixon
D000393:Air Pollutants / Q000633:toxicity; D000485:Allergens / Q000633:toxicity; D000818:Animals; D001249:Asthma / Q000150:complications / Q000276:immunology / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D004195:Disease Models, Animal; D006801:Humans; D009765:Obesity / Q000150:complications / Q000276:immunology / Q000473:pathology / Q000503:physiopathology / Q000628:therapy
D000393:Air Pollutants; D000485:Allergens
adiponectin; airway hyperreactivity; asthma; diet; leptin; obesity; phenotypes